ranitidine has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccadoro, M; Frieri, R; Gallone, G; Garino, LA; Palumbo, A; Pileri, A | 1 |
| Drivsholm, A; Klarlund, K; Mansa, B; Moesgaard, F; Nielsen, H; Nielsen, HJ; Tvede, N | 1 |
2 trial(s) available for ranitidine and Multiple Myeloma
| Article | Year |
|---|---|
Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Glucocorticoids; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Prednisone; Ranitidine; Recombinant Proteins; Remission Induction | 1992 |
The effect of ranitidine on cellular immunity in patients with multiple myeloma.
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Immunity, Cellular; Immunoglobulins; Leukocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Multiple Myeloma; Paraproteins; Ranitidine | 1990 |